ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

Henderson, Weinstein, Jukes to Present AACR Award Lectures

March 6, 1987

Tobacco Council Announces 11 New Grant Awards

January 24, 1975

DRCCA Board Approves CCOP, Limited Recompetition Of Cooperative Group Program, New Control Efforts

October 30, 1981

Rauscher Disappointed In CREG Progress

October 1, 1976

FDA to Require Data On saline Breast, Silcone Testicular Implants

January 29, 1993

After Aggressive Budgetary Trimming, At $33 Million NCI’s caBIG Remains Big

December 2, 2011